Findings from MU study could help identify people at-risk
Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.
People who may hear and see things that are not there could have symptoms of psychosis, better known as psychotic disorders. Now, researchers at the University of Missouri have found neurological markers in the human brain that can be used to detect people at-risk for developing psychotic disorders and to understand when this risk has been successfully treated.
“Psychotic disorders like schizophrenia are often lifelong and disabling for individuals,” said John Kerns, professor of psychology in the MU College of Arts and Science. “These disorders have major public health and societal costs greater than cancer. A major goal of our current research is to understand the nature of psychosis risk so we can prevent years of suffering.”
Researchers said psychotic disorders are associated with increased levels of dopamine — a chemical released by nerve cells — in a subregion of the brain called the striatum. This area is wired to process positive versus negative feedback for learning, often resulting in a person’s thoughts and actions based on what they’ve experienced in the past. Therefore, researchers suggest that psychotic disorders involve a faulty feedback in learning that then drives a person’s faulty beliefs and perceptions. However, measuring levels of dopamine in people is costly, invasive and not feasible in everyday clinical practice. In this new study, MU researchers used an MRI at MU’s Brain Imaging Center and found that people at risk for psychotic disorders exhibit evidence of dysfunction in the striatum.
“This dysfunction is most evident when performing tasks where people need to learn from positive and negative feedback,” Kerns said. “For instance, we have found that the risk for psychotic disorders involves increased activation in the striatum for positive feedback, and negative feedback involves decreased activation in the same subregion of the brain.”
Researchers believe this pattern of activation could explain symptoms of psychotic disorders. For example, activation resulting from increased positive feedback could make a person’s assumption seem truer than it really is, meanwhile activation from decreased negative feedback could make someone less likely to discard negative ideas. The team will conduct future research to examine how well an MRI can predict the risk of psychotic disorders and whether prevention treatments can ‘normalize’ MRI scans. They hope that their research will help prevent psychotic disorders, improve the lives of millions of people and greatly reduce public health costs.
The Latest on: Neurological brain markers
via Google News
The Latest on: Neurological brain markers
- Orphazyme phase 2 study of arimoclomol in Gaucher disease demonstrates marked improvements in key clinical markerson June 23, 2020 at 10:18 pm
Although some aspects of Gaucher disease are well-managed by existing drugs, these therapies do not readily cross the blood-brain barrier, leaving an urgent need for new products that can address the ...
- Selective, high-contrast detection of syngeneic glioblastoma in vivoon June 19, 2020 at 2:33 am
Glioblastoma is a highly malignant, largely therapy-resistant brain tumour. Deep infiltration of brain tissue by neoplastic cells represents the key problem of diffuse glioma. Muc ...
- 'Brain injury markers in severe COVID-19 patients identified'on June 19, 2020 at 1:32 am
The study, published in the journal Neurology ... The scientists found that a marker, known as glial fibrillary acidic protein, or GFAP, is normally present in star-shaped neuron-supportive cell type ...
- Traumatic brain injury research to examine long-term impact of concussion in childrenon June 19, 2020 at 12:16 am
Three projects on traumatic brain injury are receiving a total of $5.7 million from the Medical Research Future Fund (MRFF) over the next ...
- Cleveland Clinic receives $7.2 million to improve accuracy of MS diagnoseson June 10, 2020 at 4:41 pm
The National Institutes of Health has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis (MS) diagnoses.
- Blood Test May Help Predict Post-Concussion Recoveryon June 2, 2020 at 7:01 am
Moreover, elevations of NfL, a measure of axonal damage, were highest in veterans with repetitive traumatic brain ... in Neurology. Blood tests that include exosomal and plasma NfL markers may ...
- Alzheimer's Markers Altered With Cancer Drugon May 29, 2020 at 1:13 pm
Hippocampal volume loss was attenuated at 12 months and phospho-tau181 also was reduced at 6 months and 12 months in the nilotinib group, the authors wrote in Annals of Neurology. "The primary ...
- NIH study shows markers in blood can help identify risk for complications after mild TBIon May 28, 2020 at 7:08 am
Molecules released into the blood following mild traumatic brain injury (TBI) may be indicators of neuronal ... study of the long-term effects of mild TBI and is published in Neurology. “This study ...
- Study shows markers in blood can help identify risk for complications after mild TBIon May 28, 2020 at 5:06 am
Molecules released into the blood following mild traumatic brain injury (TBI ... the long-term effects of mild TBI and is published in Neurology. "This study brings us closer to identifying ...
via Bing News